The objective is to examine the effectiveness of ai integrated proactive thought control for social anxiety disorder and compare its effectiveness with active control group and cognitive behavioral therapy. participants with SAD will be recruited from educational setting, will get 8 therapy sessions.

NCT ID NCT07810348

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 09, 2026

Summary

Participants with Social Anxiety Disorder will be recruited from educational settings . After screening and informed consent, participants will be randomly assigned to PTC , ACG or CBT .The therapy session will be 8 session once a week, and data will be collected through psychological questionnaires in two phases at start and end of intervention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

75 people

The number who actually took part.

Started

Mar 2026

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 26 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Were between 18 and 26 years of age, corresponding to the developmental period of emerging adulthood (Arnett, 2000). * Met DSM-5 diagnostic criteria for Social Anxiety Disorder on the SCID-5-RV (First et al., 2015). * Scored at or above the clinical cutoff of 30 on the LSAS-SR, indicating clinically significant social anxiety (Mennin et al., 2002). * Were not receiving any other form of psychological intervention at the time of the study. * Had sufficient English proficiency to understand instructions and complete the assessments (Flores, 2006). * Provided written informed consent. * Possessed basic computer literacy and typing skills required for the digital tasks. Exclusion Criteria: * Were younger than 18 or older than 26 years. * Did not meet DSM-5 diagnostic criteria for Social Anxiety Disorder on the SCID-5-RV. * Scored in the clinically significant range for general anxiety (BAI ≥ 16; Beck et al., 1988) or at or above the threshold for moderate depression (BDI-II ≥ 20; Beck et al., 1996). * Were currently receiving psychological treatment for any psychiatric condition. * Had a lifetime history of a severe psychiatric disorder other than Social Anxiety Disorder (e.g., psychosis, bipolar disorder). * Had a medical or neurological condition that could interfere with task completion or valid responding. * Were unable to complete the study procedures or assessments. * Had no prior experience using a computer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Social anxiety disorder (SAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Farah Shahzadi

    Gujranwala, Punjab Province, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.